Các chẩn đoán rối loạn lipid máu ở những người mắc bệnh tiểu đường bao gồm một hoặc nhiều điều sau đây: • • • • tổng số cholesterol ≥ 200 mg / dL (5,2 mmol / L) LDL cholesterol ≥ 100 mg / dL (2,6 mmol / L) chất béo trung tính cấp độ ≥ 150 mg / dL (1,7 mmol / L) HDL cholesterol ≤ 40 mg / dL ( mmol / L) | 308 MACROVASCULAR DISEASE of The diagnosis of dyslipidemia in individuals with diabetes includes one or more of the following total cholesterol 200 mg dL mmol L LDL cholesterol 100 mg dL mmol L triglyceride level 150 mg dL mmol L HDL cholesterol 40 mg dL mmol L Note - different conversion factors are used for cholesterol and triglyceride. According to NCEP diabetes is considered a CHD risk equivalent. Thus the lipid goals for individuals with diabetes are the same as for individuals with documented CHD. For example the goal of therapy for LDL cholesterol is to achieve a level 100 mg dL mmol L . NCEP has recognized that very low levels of HDL 40 mg dL mmol L increase the risk of CHD. Conversely high levels of HDL cholesterol 60 mg dL mmol L are considered cardioprotective. Note. As with hypertension the targets for people with metabolic syndrome and dyslipidemia should be the same as for those with diabetes. While the evidence for these targets is sparse there is reason to believe that NCEP recommendations will be equally beneficial for people with metabolic syndrome. Clinical manifestations of hyperlipidemia dyslipidemia Generally there are no signs of hyperlipidemia or dyslipidemia that would be readily recognized by the patient. The one exception is lipid deposits in the eye that may be associated with changes in vision. Changes in vision however are also associated with hyperglycemia and hypertension and therefore careful evaluation to determine the cause must be carried out. Therefore it is important to maintain a program of careful surveillance using periodic fasting lipid profile determination especially in those individuals at highest risk. Once again the combination of type 2 diabetes and or metabolic syndrome and obesity with a family history of hyperlipidemia present the highest-risk group in which hyperlipidemia or dyslipidemia may be identified. Determining the starting treatment for dyslipidemia While the .
